Storage and handling
Store between 20ºC to 25ºC ( 68ºF to 77ºF) See bottom panel for lot number and expiration date
Store between 20ºC to 25ºC ( 68ºF to 77ºF) See bottom panel for lot number and expiration date
Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hidroxyzine
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If you have questions of a medical nature, please contact your pharmacist, doctor or health care profesional
Questions or comments? 561 338 5221
Store between 20ºC to 25ºC ( 68ºF to 77ºF)
See bottom panel for lot number and expiration date
Use only with enclosed dosing cup
Adults and Children 6 years and over 1 teaspoonful (5ml) ot 2 teaspoonful (10ml) once daily depending upon severity of symptoms; do not take more than 2 teaspoonful (10ml) in 24 hours
Adults 65 years and over 1 teaspoonful (5ml) once daily; do not take more than 1 teaspoonful (5ml) in 24 hours
Children 2 to under 6 years of age 1/2 teaspoonful (2.5ml) once daily.If needed, dose can be increased to a maximum of 1 teaspoon (5ml) once daily or 1/2 teaspoonful (2.5ml) every 12 hours. Do not give more than 1 teaspoonful (5ml) in 24 hours
Children under 2 years of age Ask a Doctor
Consumer with liver or kidney disease Ask a Doctor
Citric and monohydrate, Sodium Benzoate, Sodium Citrate Tribasic Dihydrate, FDC Red Nº 40, Disodium Edetate, Strawberry Essence Liquid, Glycerol, Saccharin Sodium, Sorbitol, Purified Water
Enter section text here
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1020019 | alleroff 5 MG in 5 mL Oral Solution | PSN | 4 |
| 1014673 | cetirizine HCl 5 MG in 5 mL Oral Solution | PSN | 4 |
| 1020019 | cetirizine hydrochloride 1 MG/ML Oral Solution [Alleroff] | SBD | 4 |
| 1014673 | cetirizine hydrochloride 1 MG/ML Oral Solution | SCD | 4 |
| 1020019 | Alleroff (cetirizine dihydrochloride 1 MG/ML) Oral Solution | SY | 4 |
| 1020019 | Alleroff 1 MG/ML Oral Solution | SY | 4 |
| 1020019 | Alleroff 5 MG per 5 ML Oral Solution | SY | 4 |
| 1014673 | cetirizine HCl 1 MG/ML Oral Syrup | SY | 4 |
| 1014673 | cetirizine HCl 5 MG per 5 ML Oral Solution | SY | 4 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CETIRIZINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c505bb17-4ff9-45f9-ac2d-bb9c8c9d35be | Product name | 1 | 20200304 |
| a255659f-db40-429d-8c07-5f173f330d9c | Product name | 1 | 20190402 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 16853-1261-1 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d0dd-621f-e053-dbdaa90a74ad | Drug Facts |
| 16853-1261-2 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d0dd-621f-e053-dbdaa90a74ad | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16853-1261-1 | ALLEROFF | 1 in 1 CARTON | SYRUP | 1 | 4 | |
| 16853-1261-2 | ALLEROFF | 2 in 1 PACKAGE, COMBINATION | SYRUP | 2 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 16853-1261 | ALLEROFF (CETIRIZINE HYDROCHLORIDE) SYRUP [CORPORACION INFARMASA] | 4 | Legacy NDC, 2 package rows | 20100607_b82fbeb9-021a-484b-9896-5a5b945c5827.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE | ACTIVE INGREDIENT | 64O047KTOA | 4 | |
| Cetirizine | ACTIVE MOIETY | YO7261ME24 | 4 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 4 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | 4 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | 4 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 4 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | 4 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | 4 | |
| STRAWBERRY | INACTIVE INGREDIENT | 4J2TY8Y81V | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 16853-1261 | 16853-1261-1, 16853-1261-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CETIRIZINE HYDROCHLORIDE | 64O047KTOA | ACTIB |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| SORBITOL | 506T60A25R | IACT |
| WATER | 059QF0KO0R | IACT |
| STRAWBERRY | 4J2TY8Y81V | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | SUSPENSION / ORAL | 5000 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SOLUTION / ORAL | 0.33 mg/5ml | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | WAFER / ORAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INHALANT / RESPIRATORY (INHALATION) | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | ELIXIR / ORAL | 15 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ENEMA / RECTAL | 60 mg | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | SOLUTION / ORAL | 665 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | INJECTION, SOLUTION / INTRAVENOUS | 4050 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, CHEWABLE / ORAL | 40 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / ORAL | 432 mg | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | INJECTION / INTRAMUSCULAR | 22 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / SUBCUTANEOUS | 2 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED PELLETS / ORAL | NA | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | PASTE, DENTIFRICE / DENTAL | 14 %w/w | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION/ DROPS / OPHTHALMIC | 0.25 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| SORBITOL | SORBITOL | 506T60A25R | INJECTION / INTRASYNOVIAL | 45 %w/v | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | CAPSULE / ORAL | 24 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | INJECTION / INTRA-ARTICULAR | 45 %w/v | ||
| SORBITOL | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GEL / TOPICAL | 5 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM / BUCCAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TRANSDERMAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022155-001 | CHILDREN'S ZYRTEC HIVES | CETIRIZINE HYDROCHLORIDE | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | |
| N022155-002 | CHILDREN'S ZYRTEC ALLERGY | CETIRIZINE HYDROCHLORIDE | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022155-001 | CHILDREN'S ZYRTEC HIVES | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SOLUTION / ORAL | RLD, RS | 2007-11-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022155-001 | CHILDREN'S ZYRTEC HIVES RELIEF | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022155-002 | CHILDREN'S ZYRTEC ALLERGY | 5MG/5ML | SYRUP / ORAL | RLD, RS | 2007-11-16 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 110b051e-8123-4443-b9c3-9e3181a528b2 | b82fbeb9-021a-484b-9896-5a5b945c5827 | 2010-01-15 | 110b051e-8123-4443-b9c3-9e3181a528b2 b82fbeb9-021a-484b-9896-5a5b945c5827 |
Adverse event summaries are temporarily unavailable. Other product information remains available.